to test whether variables at diagnosis can identify patients with acute nonlymphoblastic leukemia ( anl ) for whom bone marrow transplantation ( bmt ) is more likely to be of benefit and those for whom continued chemotherapy is a better approach , the association of 15 clinical and laboratory factors with outcome was investigated among 220 patients ( ages 1 to 53 years ) treated with cyclophosphamide and total body irradiation ( tbi ) followed by allogeneic bmt , and among 392 patients ( ages 13 to 50 ) administered intensive chemotherapy .
C0023467
acute
C0010583
cyclophosphamide